The iPad and MSLs: Training, Content Delivery and CRM Integration

STUDY BACKGROUND

The iPad - with its wide-ranging capabilities - has become a valuable asset for enhancing Medical Science Liaisons' interactions with thought leaders. In addition to allowing MSLs to run educational animations, iPads serve as an excellent way to manage interactions with KOLs across multiple geographic locations and therapeutic areas.

Best Practices, LLC conducted this study to help biopharmaceutical companies better understand the benefits and challenges that come with MSLs utilizing iPads in the field. In particular, this study examines how pharma companies approach the training, content delivery and CRM integration associated with MSLs' use of iPads. This study will inform MSL group leaders regarding key operational aspects of iPad use among MSL teams.


KEY TOPICS

• Training
• Content Delivery
• CRM Integration

• Current state of iPad utilization by MSL teams
• If MSLs use multiple devices, are there plans to streamline to one device in the future
• Type of tablet device deployed to MSL teams
• Department that implements and trains in the use of iPads by MSLs
• Type of training used when new tablets are deployed
• Length of training programs
• Training formats used to educate staff
• Group responsible for integrating iPads into existing computer networks
• MSL activities involving use of iPads
• Barriers to access and/or utilization of iPads
• Are CRM apps installed on iPads used in the field
• Are MSL teams integrated with CRM system
  

• Content Management Strategy: Companies should develop a content management strategy prior to device deployment. About 50% of respondents faced barriers related to content development and availability after roll-out to MSLs.
  

Industries Profiled:
Pharmaceutical; Health Care; Biotech; Biopharmaceutical; Clinical Research; Laboratories; Manufacturing


Companies Profiled:
Abbvie; Abbott Animal Health; Amgen; Acordia; Biogen Idec; Algeta; Boehringer Ingelheim; Medunik; Gilead Sciences; Jazz Pharmaceuticals; Shire; Sanofi; Cubist Pharmaceuticals; ViiV Healthcare; Mallinckrodt; United Therapeutics; LEO Pharma; Kadmon Pharmaceuticals

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.